Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Obseva Sa (OBSV)

Obseva Sa (OBSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 150,213
  • Shares Outstanding, K 57,553
  • Annual Sales, $ 20 K
  • Annual Income, $ -82,970 K
  • 60-Month Beta 0.78
  • Price/Sales 9,174.63
  • Price/Cash Flow N/A
  • Price/Book 19.22
Trade OBSV with:

Options Overview

Details
  • Implied Volatility 92.93%
  • Historical Volatility 61.15%
  • IV Percentile 4%
  • IV Rank 5.56%
  • IV High 654.37% on 11/02/20
  • IV Low 59.89% on 10/19/20
  • Put/Call Vol Ratio 0.29
  • Today's Volume 547
  • Volume Avg (30-Day) 556
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 18,001
  • Open Int (30-Day) 17,954

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.28
  • Number of Estimates 3
  • High Estimate -0.25
  • Low Estimate -0.30
  • Prior Year -0.48
  • Growth Rate Est. (year over year) +41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.53 +8.30%
on 04/20/21
3.51 -21.92%
on 03/22/21
-0.74 (-21.26%)
since 03/19/21
3-Month
2.53 +8.30%
on 04/20/21
5.55 -50.63%
on 02/22/21
-1.40 (-33.82%)
since 01/21/21
52-Week
1.86 +47.71%
on 11/03/20
6.30 -56.51%
on 07/02/20
+0.60 (+28.04%)
since 04/21/20

Most Recent Stories

More News
Thinking about buying stock in Welbilt, Ocugen, Obseva, Ericsson, or Citius Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WBT, OCGN, OBSV, ERIC, and CTXR.

ERIC : 14.08 (+3.99%)
OBSV : 2.74 (+4.98%)
OCGN : 6.50 (+17.75%)
CTXR : 1.5100 (unch)
WBT : 18.97 (+21.37%)
ObsEva Announces Year End 2020 Financial Results and Business Update

-Yselty(R) for uterine fibroids: US New Drug Application filing planned in Q2:21; European marketing approval anticipated in Q4:21-

OBSV : 2.74 (+4.98%)
ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference

Geneva, Switzerland and Boston, MA - March 3, 2021 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health,...

OBSV : 2.74 (+4.98%)
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference

OBSV : 2.74 (+4.98%)
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares

OBSV : 2.74 (+4.98%)
ObsEva Provides Business Outlook for 2021

OBSV : 2.74 (+4.98%)
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares

OBSV : 2.74 (+4.98%)
Implied Volatility Surging for ObsEva (OBSV) Stock Options

Investors need to pay close attention to ObsEva (OBSV) stock based on the movements in the options market lately.

OBSV : 2.74 (+4.98%)
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OBSV, DBVT, BB, FPRX, and BNGO.

BNGO : 5.52 (+2.60%)
DBVT : 5.89 (-1.51%)
FPRX : 38.00 (+0.03%)
OBSV : 2.74 (+4.98%)
BB : 8.16 (-0.61%)
ObsEva Provides Update on Yselty(R) (Linzagolix) Clinical Development Program

OBSV : 2.74 (+4.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.

See More

Key Turning Points

3rd Resistance Point 2.86
2nd Resistance Point 2.78
1st Resistance Point 2.70
Last Price 2.74
1st Support Level 2.53
2nd Support Level 2.44
3rd Support Level 2.36

See More

52-Week High 6.30
Fibonacci 61.8% 4.60
Fibonacci 50% 4.08
Fibonacci 38.2% 3.55
Last Price 2.74
52-Week Low 1.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar